Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Over the last 12 months, insiders at Cosmos Health Inc. have bought $499,806 and sold $0 worth of Cosmos Health Inc. stock.
On average, over the past 5 years, insiders at Cosmos Health Inc. have bought $3.12M and sold $682,752 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Siokas Grigorios (Chief Executive Officer) — $449,806. Terzis Georgios (Chief Financial Officer) — $50,000.
The last purchase of 47,904 shares for transaction amount of $40,000 was made by Siokas Grigorios (Chief Executive Officer) on 2025‑01‑16.
2025-01-16 | Chief Executive Officer | 47,904 0.2026% | $0.83 | $40,000 | +2.68% | |||
2025-01-15 | Chief Executive Officer | 62,500 0.281% | $0.80 | $50,000 | +5.78% | |||
2025-01-14 | Chief Executive Officer | 87,247 0.3827% | $0.69 | $60,000 | +21.42% | |||
2025-01-13 | Chief Executive Officer | 163,666 0.7036% | $0.61 | $100,000 | +33.80% | |||
2024-12-20 | Chief Executive Officer | 257,334 1.073% | $0.58 | $150,000 | +17.09% | |||
2024-12-20 | Chief Financial Officer | 85,778 0.3577% | $0.58 | $50,000 | +17.09% | |||
2024-02-16 | Chief Executive Officer | 60,000 0.3544% | $0.83 | $49,806 | -11.63% | |||
2023-10-12 | Chief Executive Officer | 6,712 0.942% | $23.66 | $158,806 | -22.48% | |||
2023-07-20 | Chief Executive Officer | 181,451 2.2312% | $2.48 | $449,998 | -44.88% | |||
2023-06-06 | Chief Executive Officer | 4,474 0.2639% | $23.92 | $107,018 | -71.73% | |||
2023-04-27 | Chief Executive Officer | 4,474 0.2893% | $24.64 | $110,239 | -67.13% | |||
2023-04-21 | Chief Executive Officer | 4,474 0.3236% | $24.49 | $109,568 | -62.38% | |||
2023-04-07 | Chief Executive Officer | 2,238 0.1663% | $24.37 | $54,540 | -55.81% | |||
2022-12-19 | Chief Executive Officer | 260,870 20.4991% | $11.50 | $3M | -59.35% | |||
2022-11-28 | Sale | Chief Executive Officer | 498 – | $0.62 | $310 | +432.76% | ||
2022-11-28 | Chief Executive Officer | 801,261 1.7812% | $0.62 | $497,984 | +432.76% | |||
2022-10-20 | Chief Executive Officer | 12.5M 35.4414% | $0.12 | $1.5M | +3411.36% | |||
2022-06-15 | Chief Executive Officer | 1,500 – | $0.62 | $932 | -1.49% | |||
2021-12-08 | Chief Executive Officer | 125,000 1.3275% | $6.00 | $750,000 | -77.86% | |||
2021-10-22 | Sale | Chief Executive Officer | 341,900 0.3987% | $0.82 | $281,559 | -74.19% |
Siokas Grigorios | Chief Executive Officer | 4135631 17.7803% | $0.86 | 24 | 36 | +383.15% |
Terzis Georgios | Chief Financial Officer | 727263 3.1267% | $0.86 | 1 | 0 | |
MAVROGIANNIS VASILEIOS | 10 percent owner | 9700227 41.7042% | $0.86 | 2 | 8 | |
DRAKOPOULOS PANAGIOTIS | CEO | 8758561 37.6557% | $0.86 | 0 | 7 | |
GOLDSTEIN PETER | 157100 0.6754% | $0.86 | 1 | 0 |